Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-11-2014 | Letter to the Editor

Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology

Authors: Eric Laffon, Roger Marthan

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2014

Excerpt

Dear Sir, …

Hasenclever D, Kurch L, Mauz-Körholz C, Elsner A, Goergi T, Wallace H, et al. qPET—a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging 2014;41:1301–8.PubMedCrossRef

Bland JM, Altman DG. Measurement error. BMJ 1996;313:744–6.PubMedCrossRef

Laffon E, Lamare F, de Clermont H, Burger IA, Marthan R. Variability of average SUV from several hottest voxel is lower than that of SUVmax and SUVpeak. Eur Radiol 2014;24:1964–70. doi:10.1007/s00330-014-3222-x.PubMedCrossRef

Boktor RR, Walker G, Stacey R, Gledhill S, Pitman AG. Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET. J Nucl Med 2013;54:677–82.PubMedCrossRef

Title: Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology
Authors: Eric Laffon
Roger Marthan
Publication date: 01-11-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-014-2879-3

At a glance: The STEP trials

Springer Medicine

Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2014

Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo

Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients

Erratum to: Do CSF levels of t-Tau, p-Tau and β1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease

Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma

Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma

FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment